AsOf

Amgen · cash and equivalents13,190,000,000 United States dollar

valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted

What the statuses mean

Valid from
2026-09-30
Valid until
still holds
Published
2026-11-04
Recorded by AsOf
2026-11-08
Checked
2026-11-08 · parsed from the SEC filing
Confidence
0.95

Sources

Cite this claim

Each form names the value, its as-of date (2026-09-30), the day you read it (2026-11-09), the claim's stable URL and id and its primary source. The URL never changes: a superseded claim stays at the same address.

Plain text
AsOf. "Amgen cash and equivalents: 13,190,000,000 United States dollar", as of 2026-09-30. Claim clm_682A30955369, https://asof.is/claim/clm_682A30955369, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815426000155/0000318154-26-000155-index.htm.
APA
AsOf. (2026). Amgen cash and equivalents: 13,190,000,000 United States dollar (as of 2026-09-30) [Record clm_682A30955369]. Retrieved November 9, 2026, from https://asof.is/claim/clm_682A30955369 (source: https://www.sec.gov/Archives/edgar/data/318154/000031815426000155/0000318154-26-000155-index.htm)
BibTeX
@misc{asof_clm_682A30955369,
  author = {AsOf},
  title = {Amgen cash and equivalents: 13,190,000,000 United States dollar},
  year = {2026},
  howpublished = {\url{https://asof.is/claim/clm_682A30955369}},
  note = {Claim clm\_682A30955369, as of 2026-09-30; source: https://www.sec.gov/Archives/edgar/data/318154/000031815426000155/0000318154-26-000155-index.htm},
  urldate = {2026-11-09}
}

Supersedes

On the record

/claim/clm_682A30955369.md/v1/claims/clm_682A30955369submit a correction